Pediatrics Doctors in Baton Rouge, LA Accepting Medicare
186 Pediatrics doctors found. Showing 181 - 186
 Kay Lynnette Miller, DO Pediatrics Medicare: Medicare Enrolled Practice Location: 8300 Constantin Blvd, Baton Rouge, LA 70809 Phone: 225-374-1410 Fax: 225-374-1616 |
Ms. Rebecca Ellen Hook, Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 8300 Constantin Blvd, Baton Rouge, LA 70809 Phone: 225-374-1410 Fax: 225-374-1616 |
Dr. Charmaine Lastrapes Venters, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5439 Airline Hwy, Baton Rouge, LA 70805 Phone: 225-358-4853 Fax: 225-358-2450 |
Marcela Fernanda Astudillo Jarrin, M.D Pediatrics - Pediatric Endocrinology Medicare: Medicare Enrolled Practice Location: 8200 Constantin Blvd Fl 4, Baton Rouge, LA 70809 Phone: 225-765-5500 Fax: 225-374-1537 |
 David Garrett Hill, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5131 Odonovan Dr, Ste. 301, Baton Rouge, LA 70808 Phone: 225-765-5500 Fax: 225-490-0396 |
Dr. Karen Renee Williams, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1401 N Foster Dr, Baton Rouge, LA 70806 Phone: 225-987-9179 |
News Archive
Hydroxychloroquine should not be used to prevent COVID-19, says WHO expert panel
The anti-inflammatory drug hydroxychloroquine should not be used to prevent infection in people who do not have covid-19, say a WHO Guideline Development Group (GDG) panel of international experts in The BMJ today.
Researchers identify COVID-19 drug lead treatments
An international team of researchers has tested more than 10,000 compounds to identify six drug candidates that may help treat COVID-19.
Caffeine in coffee may help small blood vessels work better
The caffeine in a cup of coffee might help your small blood vessels work better, according to research presented at the American Heart Association's Scientific Sessions 2013.
Distinct structures of tau protein aggregates may help determine type of dementia, study shows
The distinct structures of toxic protein aggregates that form in degenerating brains determine which type of dementia will occur, which regions of brain will be affected, and how quickly the disease will spread, according to a study from the Peter O'Donnell Jr. Brain Institute.
Most promising drugs in development for metabolic syndrome
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that emerging agents from Metabolex/Johnson & Johnson, Merck, Novartis, and Amylin/Eli Lilly are among the most promising drugs in development for metabolic syndrome.
› Verified 1 days ago
Internal Medicine
Pediatrics
Emergency Medicine
Family Medicine
Obstetrics & Gynecology
Psychiatry & Neurology
Radiology
Surgery
Cardiovascular Disease
Anesthesiology
Orthopaedic Surgery